Physician profile
Ryan Christopher Murdock
NPI 1790909281
$1,024.01
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $520 · 2022: $187.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $502.80 | 2020 | |
| Medtronic, INC. | $186.84 | 2022 | |
| Nuvasive, INC. | $180.36 | 2019 | |
| Medtronic USA, INC. | $93.68 | 2019 | |
| Depuy Synthes Sales INC. | $60.33 | 2019-2020 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$90,306.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Murdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.